Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.
Longhi A, Errani C, Battaglia M, Alberghini M, Ferrari S, Mercuri M, Molinari M.
Ear Nose Throat J. 2011 Jun;90(6):E11-5. doi: 10.1177/014556131109000610.
PMID:21674455
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.
Costa PA, Arora A, Fernandez Y, Yi I, Bakkila B, Tan H, Barreto Coelho P, Campoverde L, Hardy N, Bialick S, Espejo Freire A, D'Amato GZ, Chang YC, Mesenger JP, Subhawong T, Haims A, Hurwitz M, Olino K, Turaga K, Deshpande H, Trent J.
Cancer. 2025 Jan 1;131(1):e35647. doi: 10.1002/cncr.35647. Epub 2024 Nov 14.
PMID:39543805
Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature.
Wcislo G, Szarlej-Wcislo K, Szczylik C.
J Cancer Res Clin Oncol. 2007 Aug;133(8):533-8. doi: 10.1007/s00432-007-0198-9. Epub 2007 Apr 24.
PMID:17453242
The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K, Kawashima H, Kawai A, Yoshida M, Nishida Y.
Jpn J Clin Oncol. 2020 Oct 22;50(11):1274-1281. doi: 10.1093/jjco/hyaa125.